|
Nexia Biotechnologies` Shareholders Elects New Board Of Directors Monday November 14, 10:40 am ET EDMONTON, Nov. 14 /CNW Telbec/ - Nexia Biotechnologies Inc. (NEX: NXB) announced that at the annual meeting of shareholders held in Toronto on November 11, 2005, Messrs. David L. Tonken, Gregory B. Matthews, and Dr. Jeffrey D. Turner were elected to the Board of Directors of the Corporation. ADVERTISEMENT Dr. Turner is a biotechnology consultant and the former President, CEO and founder of Nexia. Mr. Matthews, a member of the Law Society of Alberta and of the Upper Canada Law Society, is a managing director of Cavalon Capital Partners Ltd. Mr. Tonken, previously the President of Scout Capital Corp. (now Birchcliff Energy Inc. TSX: BIR) and Chairman of the Board, Synsorb Biotech Inc. (now Iteration Energy Ltd. TSX:ITX), has assumed the position of President and CEO of Nexia. Mr. Tonken commented "We felt the company was best served by directors who had a significant financial investment in Nexia. Management will now work on a full-time basis to grow the company. We are going to assess all our assets and allocate capital in a strategic manner. We will consider new businesses, new financing, and new partnerships. We recognize our PharmAthene investment as a key component of Nexia`s future and will structure our business transactions to comply with our PharmAthene obligations and protect the value of the investment for our shareholders. We would like to take this opportunity to thank the past directors for their hard work and for assisting with the transition." ABOUT NEXIA For more information, please visit Nexia`s website at www.nexiabiotech.com. Nexia`s complete continuing disclosure documents, including: the first quarter 2006 report and interim financial statements, the 2005 Annual Report, the MD&A and consolidated financial statements for the fiscal 2005 can be accessed through Company`s securities filings at www.sedar.com. FORWARD-LOOKING STATEMENT AND OTHER IMPORTANT INFORMATION Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes"; "anticipates"; "intends"; "plans"; "expects"; "estimates"; or similar statements are forward-looking statements. Such statements reflect management`s current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors. Nexia specifically disclaims any obligation to update these forward-looking statements. Nexia assumes no responsibility with respect to any information contained herein relating to any entity other than itself. Website addresses referred to herein are provided for convenience purposes only and information contained therein is not incorporated herein by reference, nor does Nexia assume any responsibility in connection therewith. For more information, please visit www.sedar.com. BioSteel(R) is a registered trademark of Nexia Biotechnologies Inc. in Canada. For further information David L. Tonken, President and CEO, Nexia Biotechnologies Inc., (780) 486-2317, tonken@icrossroads.com -------------------------------------------------------------------------------- Source: NEXIA BIOTECHNOLOGIES INC. |
|
| aus der Diskussion: | Nexia Biotech- große Zukunftsaussichten |
| Autor (Datum des Eintrages): | Bombenleger (22.11.05 10:57:46) |
| Beitrag: | 40 von 43 (ID:18935155) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |